Lmr Partners LLP 9 Meters Biopharma, Inc. Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $27,996 - $68,914	107,679 New	107,679 $28,000
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.5 $109,139 - $157,413	-104,942 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $88,151 - $226,674	104,942 New	104,942 $123,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.